Skip to content

Clinical trials

Active, not recruiting Ovarian Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Active, not recruiting Country / region: South Korea Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20132
20141
20151
20163
20194
20203
20215
20225
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
National Cancer Institute (NCI)3
CanariaBio Inc.2
EMD Serono Research & Development Institute, Inc.2
Hoffmann-La Roche2
AbbVie1
Alterome Therapeutics, Inc.1
BicycleTx Limited1
Corcept Therapeutics1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms29
Carcinoma, Non-Small-Cell Lung8
Fallopian Tube Neoplasms8
Breast Neoplasms5
Colorectal Neoplasms5
Endometrial Neoplasms5
Neoplasms5
Carcinoma, Ovarian Epithelial4
Head and Neck Neoplasms4
Pancreatic Neoplasms4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.